The program aims at
- Developing clinically-relevant, patient-derived, phenotypically responsive, adult stem cell based predictive platforms to test therapeutic vulnerabilities of molecules trans-differentiating adult stem cells to neurons
- Developing novel natural product-inspired functional, druggable molecular entities with neurogenesis and neuroprotective properties for treating neurological disorders
- Integrating highly unique chemical toolbox with proprietary stem cell based predictive screening platform(s) to discover novel small molecules, functioning as neuro-genesis and neuro-protective agents to treat Alzheimer’s, Parkinson’s and ALS
- To explore PINK and Parkin as targets in Neurodegeneration
